Gary Visner

5.5k total citations
111 papers, 3.6k citations indexed

About

Gary Visner is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Gary Visner has authored 111 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Surgery, 45 papers in Pulmonary and Respiratory Medicine and 28 papers in Molecular Biology. Recurrent topics in Gary Visner's work include Transplantation: Methods and Outcomes (42 papers), Heme Oxygenase-1 and Carbon Monoxide (17 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers). Gary Visner is often cited by papers focused on Transplantation: Methods and Outcomes (42 papers), Heme Oxygenase-1 and Carbon Monoxide (17 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers). Gary Visner collaborates with scholars based in United States, Austria and United Kingdom. Gary Visner's co-authors include Harry S. Nick, Anupam Agarwal, Kaifeng Liu, William C. Dougall, Dani S. Zander, James M. Wilson, Hanzhong Liu, Fuhua Lu, Hanzhong Liu and Bradley S. Fletcher and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Circulation.

In The Last Decade

Gary Visner

106 papers receiving 3.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Gary Visner 1.4k 842 764 429 407 111 3.6k
Kai M. Schmidt‐Ott 2.1k 1.5× 686 0.8× 871 1.1× 246 0.6× 601 1.5× 106 5.8k
Kamyar Zahedi 1.4k 1.0× 729 0.9× 633 0.8× 300 0.7× 742 1.8× 73 5.3k
Jan‐Luuk Hillebrands 1.5k 1.0× 1.2k 1.4× 640 0.8× 396 0.9× 401 1.0× 173 6.1k
Sharmila Fagoonee 1.2k 0.8× 1.1k 1.3× 455 0.6× 231 0.5× 772 1.9× 193 3.8k
Theodoros Eleftheriadis 860 0.6× 554 0.7× 357 0.5× 305 0.7× 497 1.2× 196 3.8k
Fumitaka Ohsuzu 975 0.7× 1.0k 1.2× 780 1.0× 521 1.2× 640 1.6× 204 5.0k
Gediminas Cepinskas 1.2k 0.8× 591 0.7× 401 0.5× 282 0.7× 514 1.3× 113 3.5k
R. Zimmermann 1.2k 0.8× 690 0.8× 278 0.4× 358 0.8× 435 1.1× 156 3.8k
Attila J. Szabó 884 0.6× 559 0.7× 476 0.6× 216 0.5× 414 1.0× 202 3.7k
Masanobu Kawakami 1.4k 1.0× 1.1k 1.3× 633 0.8× 275 0.6× 837 2.1× 193 5.2k

Countries citing papers authored by Gary Visner

Since Specialization
Citations

This map shows the geographic impact of Gary Visner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Visner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Visner more than expected).

Fields of papers citing papers by Gary Visner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Visner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Visner. The network helps show where Gary Visner may publish in the future.

Co-authorship network of co-authors of Gary Visner

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Visner. A scholar is included among the top collaborators of Gary Visner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Visner. Gary Visner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dahlberg, Suzanne E., et al.. (2024). Gastrointestinal complications in pediatric lung transplant recipients: Incidence, risk factors, and effects on patient outcomes. Pediatric Transplantation. 28(1). e14665–e14665. 1 indexed citations
2.
Mangano, Christina Mora, et al.. (2024). Cardiac Comorbidity and Exercise Intolerance in Bilateral Lung Transplant Recipients Followed at a Pediatric Center. Pediatric Cardiology. 46(7). 1906–1915.
3.
Hamilton, Thomas E., Hester F. Shieh, C. Jason Smithers, et al.. (2024). Outcomes of surgical treatment of tracheobronchomalacia in children. Pediatric Pulmonology. 59(7). 1922–1931. 5 indexed citations
4.
Visner, Gary, et al.. (2023). A novel ex vivo tracheobronchomalacia model for airway stent testing and in vivo model refinement. Journal of Thoracic and Cardiovascular Surgery. 166(3). 679–687.e1. 2 indexed citations
5.
Mohammed, Somala, Ali Kamran, Gary Visner, et al.. (2023). Primary Posterior Tracheopexy at Time of Esophageal Atresia Repair Significantly Reduces Respiratory Morbidity. Journal of Pediatric Surgery. 59(1). 10–17. 5 indexed citations
6.
7.
Finan, Jon, Antonio Coppolino, Andreas Seyfang, et al.. (2022). IL-33 mediates Pseudomonas induced airway fibrogenesis and is associated with CLAD. The Journal of Heart and Lung Transplantation. 42(1). 53–63. 3 indexed citations
8.
Sheils, Catherine A., et al.. (2021). High altitude simulation testing in patients with congenital diaphragmatic hernia. Journal of Pediatric Surgery. 57(2). 195–198. 5 indexed citations
9.
Cui, Ye, et al.. (2017). Lymphatic Vessels: The Next Frontier in Lung Transplant. Annals of the American Thoracic Society. 14(Supplement_3). S226–S232. 25 indexed citations
10.
Toprak, Demet, et al.. (2016). Outcomes of mechanical support in a pediatric lung transplant center. Pediatric Pulmonology. 52(3). 360–366. 16 indexed citations
11.
Vergani, Andrea, Picheng Zhao, Moufida Ben Nasr, et al.. (2014). Inhibition of the Purinergic Pathway Prolongs Mouse Lung Allograft Survival. American Journal of Respiratory Cell and Molecular Biology. 51(2). 300–310. 26 indexed citations
12.
Christou, Helen, Li Liu, Gary Visner, et al.. (2013). Endothelial Indoleamine 2,3-Dioxygenase Protects against Development of Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 188(4). 482–491. 43 indexed citations
13.
Iken, Khadija, Kaifeng Liu, Hanzhong Liu, et al.. (2012). Indoleamine 2,3-Dioxygenase and Metabolites Protect Murine Lung Allografts and Impair the Calcium Mobilization of T Cells. American Journal of Respiratory Cell and Molecular Biology. 47(4). 405–416. 25 indexed citations
14.
Bizargity, Peyman, Kaifeng Liu, Liqing Wang, Wayne W. Hancock, & Gary Visner. (2012). Inhibitory Effects of Pirfenidone on Dendritic Cells and Lung Allograft Rejection. Transplantation. 94(2). 114–122. 37 indexed citations
15.
Liu, Hanzhong, Li Liu, Kaifeng Liu, et al.. (2009). Reduced Cytotoxic Function of Effector CD8+ T Cells Is Responsible for Indoleamine 2,3-Dioxygenase-Dependent Immune Suppression. The Journal of Immunology. 183(2). 1022–1031. 81 indexed citations
16.
Danziger‐Isakov, Lara, Sarah Worley, Marian G. Michaels, et al.. (2009). The Risk, Prevention, and Outcome of Cytomegalovirus After Pediatric Lung Transplantation. Transplantation. 87(10). 1541–1548. 47 indexed citations
17.
Visner, Gary, et al.. (2006). Bone Marrow Stem Cells as a Vehicle for Delivery of Heme Oxygenase-1 Gene. Stem Cells and Development. 15(1). 79–86. 10 indexed citations
18.
Lu, Fuhua, et al.. (2004). Heme Oxygenase-1 Expression in Human Lungs with Cystic Fibrosis and Cytoprotective Effects against Pseudomonas Aeruginosa In Vitro. American Journal of Respiratory and Critical Care Medicine. 170(6). 633–640. 66 indexed citations
19.
Visner, Gary, et al.. (2003). Graft protective effects of heme oxygenase 1 in mouse tracheal transplant-related obliterative bronchiolitis1. Transplantation. 76(4). 650–656. 19 indexed citations
20.
Nick, Harry S., et al.. (1995). Effects of Vasoactive and Inflammatory Mediators on Endothelin-1 Expression in Pulmonary Endothelial Cells. American Journal of Respiratory Cell and Molecular Biology. 12(5). 503–512. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kai M. Schmidt‐Ott Breakdown of academic impact, for papers by Kamyar Zahedi Breakdown of academic impact, for papers by Jan‐Luuk Hillebrands Breakdown of academic impact, for papers by Sharmila Fagoonee Breakdown of academic impact, for papers by Theodoros Eleftheriadis Breakdown of academic impact, for papers by Fumitaka Ohsuzu Breakdown of academic impact, for papers by Gediminas Cepinskas Breakdown of academic impact, for papers by R. Zimmermann Breakdown of academic impact, for papers by Attila J. Szabó Breakdown of academic impact, for papers by Masanobu Kawakami
Rankless by CCL
2026